Scripps 37th Annual New Treatments in Chronic Liver Disease 2023

Name: Scripps 37th Annual New Treatments in Chronic Liver Disease 2023
SKU: 4709
Availability: InStock

$30.00

This Product is shared via google drive download link, So please share your correct Gmail id while placing the order .Please note that there are no CME points or certificate associated with this course Samples for Courses Can be found here : Free Samples Here!

15 videos + 1 pdf, size: 7.48 GB

Categories: GIT COURSES, Internal Medicine Tags: git, Internal Medicine

Description

Scripps 37th Annual New Treatments in Chronic Liver Disease 2023

This conference will review the latest medications and therapies in liver treatment and transplantation. The results of trials and real world data using oral drugs to treat chronic viral hepatitis B and C, non-alcoholic fatty liver diseases, primary biliary cirrhosis, primary sclerosing cholangitis, hepatocellular carcinoma and complications of end-stage liver disease including thrombocytopenia will be reviewed in detail. New Treatments in Chronic Liver Disease is a comprehensive yet concise program for updating physicians on these and other commonly encountered problems in the treatment of liver diseases.

+ Include: 15 videos + 1 pdf, size: 7.48 GB

Educational Objectives

After attending this live activity, participants should be able to:

Cite new therapies for curing Delta Hepatitis, HBV and HCV elimination.
Discuss potential new treatments for Wilson’s Disease.
Summarize non-invasive markers and therapies for NAFLD and NASH.
Evaluate drugs in development for PBC and PSC.
Employ strategies for treating and managing HCC, ascites and hepatorenal syndrome.

Target Audience

Hepatologists
Gastroenterologists
Infectious Disease Specialists

+ Topics:

brochure_liver23_compressed.pdf
CHRONIC HEPATITIS B, C, AND DELTA DEBATE Cessation of HBV Anti-Viral Therapy to Achieve Cure.mp4
CHRONIC HEPATITIS B, C, AND DELTA DEBATE Functional Cure for HBV.mp4
CHRONIC HEPATITIS B, C, AND DELTA DEBATE New Treatments for Delta Hepatitis.mp4
CHRONIC HEPATITIS B, C, AND DELTA DEBATE The Road to HCV Elimination in the U.S.mp4
CHRONIC HEPATITIS B, C, AND DELTA Panel Discussion Q&A.mp4
ESLD, HCC AND TRANSPLANTATION Panel Discussion Q&A.mp4
ESLD, HCC AND TRANSPLANTATION Update on Management of Ascites and HRS.mp4
ESLD, HCC AND TRANSPLANTATION When to Refer for Liver Transplantation.mp4
ESLD, HCC AND TRANSPLANTATION WILLIAM S. HAUBRICH LECTURE Advances in HCC Diagnosis and Treatment.mp4
METABOLIC AND CHOLESTATIC DISORDERS DEBATE New Treatments for Wilson’s Disease.mp4
METABOLIC AND CHOLESTATIC DISORDERS DEBATE Non-Invasive Diagnosis for NAFLD and NASH.mp4
METABOLIC AND CHOLESTATIC DISORDERS DEBATE Updates for PBC and PSC.mp4
METABOLIC AND CHOLESTATIC DISORDERS DEBATE Which Class of Drug is the Best Treatment for NASH.mp4
METABOLIC AND CHOLESTATIC DISORDERS New Treatments for NASH.mp4
METABOLIC AND CHOLESTATIC DISORDERS Panel Discussion Q&A.mp4